by devani | Jul 19, 2023 | CDO
A new study by Washington University School of Medicine in St. Louis found that two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19. The two drugs are typically used to treat inflammatory...
by devani | Jul 6, 2023 | CDO
As of June 30, Washington 211 no longer serves as the state’s COVID-19 Hotline. The Washington State Department of Health (DOH) ended its three-year collaboration with 211, redirecting all COVID-19 related questions to their information hotline...
by devani | Jul 6, 2023 | CDO
The Washington State Childhood Vaccine Program (CVP) gives recommended vaccinations for those under the age of 19 to medical providers at no cost, reducing their patients’ financial barriers to immunizations. COVID-19 vaccines are expected to be added to CVP...
by devani | Jul 6, 2023 | CDO
Two federal committees recently met to discuss upcoming updates to the COVID-19 vaccine. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met and voted to update the vaccine’s current composition to a monovalent XBB-lineage....
by devani | Jun 21, 2023 | CDO
The Washington State Health Care Authority (HCA) is requesting applications for their Community-Based Organization Substance Use Disorder (SUD Px) and Mental Health Promotion Project (MHPP) Enhancement Grants. HCA is awarding funds ranging from $10,000 –...
